Alnylam Pharmaceuticals (ALNY) Stock Forecast for 2024–2028. Sell or Buy Prediction







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

Alnylam Pharmaceuticals (ALNY) Stock Forecast for 2024–2028. Sell or Buy?

Updated: March 18, 2024 (10:40)

Sector: Healthcare

The share price of Alnylam Pharmaceuticals, Inc. (ALNY) now

Latest session on the 27th of March for
Alnylam Pharmaceuticals, Inc. is positive
Trading Volume: 463043
Open: 152.83 /  High: 155.28 /  Low: 150.4
What analysts predict: $222.59
52-week High/Low: $218.88 / $143.52

50/200 Day Moving Average: $164.18 / $178.3

This figure corresponds to the Average Price over the previous 50/200 days. For Alnylam Pharmaceuticals stocks, the 50-day moving average is the resistance level today.

For Alnylam Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in Alnylam Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alnylam Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one Alnylam Pharmaceuticals share be worth in 2024 - 2028?

When should I take profit in Alnylam Pharmaceuticals stock? When should I record a loss on Alnylam Pharmaceuticals stock? What are analysts' forecasts for Alnylam Pharmaceuticals stock? What is the future of Alnylam Pharmaceuticals stock? We forecast Alnylam Pharmaceuticals stock performance using neural networks based on historical data on Alnylam Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Alnylam Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alnylam Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Alnylam Pharmaceuticals stock

The chart below shows the historical price of Alnylam Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alnylam Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the discovery, development and commercialization of RNA interference (RNAi) therapeutics. The company’s line of investigated RNAi therapies focuses on genetic drugs, cardiovascular diseases, liver infections, and central nervous system (CNS) / eye diseases.

Alnylam Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
May 29 129.75 127.62 130.42 2.19
May 30 130.32 128.56 131.00 1.90
May 31 129.31 128.20 130.75 1.99
Jun 01 125.94 123.72 127.12 2.75
Jun 02 128.40 125.73 129.43 2.95
Jun 03 127.80 126.04 129.49 2.74
Jun 04 127.27 125.68 129.52 3.05
Jun 05 125.65 123.95 127.51 2.87
Jun 06 127.77 126.67 129.33 2.10
Jun 07 128.93 126.32 131.21 3.88
Jun 08 130.47 129.12 133.09 3.07
Jun 09 133.09 131.87 133.95 1.57
Jun 10 134.40 132.27 135.69 2.59
Jun 11 133.81 132.07 135.58 2.66
Jun 12 133.63 131.27 135.96 3.57
Jun 13 137.11 135.11 138.21 2.30
Jun 14 136.00 133.17 137.81 3.48
Jun 15 135.75 134.55 136.85 1.70
Jun 16 135.61 132.93 137.59 3.50
Jun 17 133.50 132.80 135.48 2.01
Jun 18 134.96 132.67 137.20 3.41
Jun 19 136.71 134.79 139.16 3.24
Jun 20 139.87 137.65 141.51 2.80
Jun 21 141.58 138.90 142.83 2.84
Jun 22 140.88 138.80 143.52 3.40
Jun 23 140.92 138.72 141.73 2.17
Jun 24 142.31 139.98 144.53 3.25
Jun 25 141.94 139.80 142.68 2.06
Jun 26 142.98 140.52 145.43 3.49
Jun 27 141.82 139.46 143.41 2.83

Alnylam Pharmaceuticals Daily Price Targets


Alnylam Pharmaceuticals Stock Forecast 05-29-2022.

Forecast target price for 05-29-2022: $129.75.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.147%.
Pessimistic target level: 127.62
Optimistic target level: 130.42

Alnylam Pharmaceuticals Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $130.32.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 1.863%.
Pessimistic target level: 128.56
Optimistic target level: 131.00

Alnylam Pharmaceuticals Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $129.31.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 1.955%.
Pessimistic target level: 128.20
Optimistic target level: 130.75

Alnylam Pharmaceuticals Stock Forecast 06-01-2022.

Forecast target price for 06-01-2022: $125.94.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.679%.
Pessimistic target level: 123.72
Optimistic target level: 127.12

Alnylam Pharmaceuticals Stock Forecast 06-02-2022.

Forecast target price for 06-02-2022: $128.40.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.863%.
Pessimistic target level: 125.73
Optimistic target level: 129.43

Alnylam Pharmaceuticals Stock Forecast 06-03-2022.

Forecast target price for 06-03-2022: $127.80.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.669%.
Pessimistic target level: 126.04
Optimistic target level: 129.49

ALNY (ALNY) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Apr. 155.75 148.38 163.63 9.32
May. 169.80 158.03 182.13 13.23
Jun. 170.92 166.78 182.95 8.84
Jul. 176.94 170.32 189.39 10.07
Aug. 182.39 178.37 195.63 8.82
Sep. 201.65 195.88 208.97 6.26
Oct. 200.54 189.73 212.45 10.69
Nov. 209.58 199.21 225.49 11.66
Dec. 215.11 205.41 225.76 9.01

Alnylam Pharmaceuticals forecast for this year


Alnylam Pharmaceuticals Stock Prediction for Apr 2024

An uptrend is forecast for this month with an optimal target price of $155.75. Pessimistic: $148.38. Optimistic: $163.63


Alnylam Pharmaceuticals Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $169.799. Pessimistic: $158.03. Optimistic: $182.13


Alnylam Pharmaceuticals Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $170.919. Pessimistic: $166.78. Optimistic: $182.95


Alnylam Pharmaceuticals Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $176.936. Pessimistic: $170.32. Optimistic: $189.39


Alnylam Pharmaceuticals Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $182.385. Pessimistic: $178.37. Optimistic: $195.63


Alnylam Pharmaceuticals Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $201.645. Pessimistic: $195.88. Optimistic: $208.97


Alnylam Pharmaceuticals Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $200.536. Pessimistic: $189.73. Optimistic: $212.45


Alnylam Pharmaceuticals Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $209.58. Pessimistic: $199.21. Optimistic: $225.49


Alnylam Pharmaceuticals Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $215.113. Pessimistic: $205.41. Optimistic: $225.76



Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 235.94 216.47 244.24 11.37
Feb 248.91 240.97 263.15 8.43
Mar 229.47 222.91 245.12 9.06
Apr 220.64 202.68 235.44 13.92
May 232.29 215.94 248.64 13.15
Jun 241.23 223.45 251.31 11.09
Jul 244.42 229.63 261.62 12.23
Aug 236.62 225.95 249.89 9.58
Sep 259.78 246.35 275.50 10.58
Oct 279.50 261.05 291.18 10.35
Nov 274.58 264.92 283.34 6.50
Dec 265.22 252.97 282.14 10.34

Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 275.72 256.61 296.04 13.32
Feb 287.25 262.60 303.68 13.53
Mar 301.47 292.51 324.01 9.72
Apr 314.40 305.41 339.64 10.08
May 335.49 317.04 356.16 10.98
Jun 370.18 359.19 390.95 8.12
Jul 357.97 327.65 383.17 14.49
Aug 372.54 349.59 384.83 9.16
Sep 380.73 347.23 413.40 16.01
Oct 359.37 344.75 377.16 8.59
Nov 375.19 347.54 391.69 11.27
Dec 389.63 367.34 422.63 13.08

Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 425.20 397.14 438.30 9.39
Feb 421.93 407.08 432.61 5.90
Mar 458.60 432.36 496.93 12.99
Apr 441.44 422.99 455.53 7.14
May 465.72 451.89 475.97 5.06
Jun 500.05 485.20 544.05 10.82
Jul 509.95 492.56 543.04 9.30
Aug 513.31 496.94 533.64 6.88
Sep 521.22 492.55 537.27 8.32
Oct 497.71 476.36 527.82 9.75
Nov 491.14 454.41 521.40 12.85
Dec 496.55 459.95 536.96 14.34

Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 491.08 469.48 529.98 11.42
Feb 512.69 467.57 549.35 14.89
Mar 534.12 521.78 558.21 6.53
Apr 527.07 494.60 545.62 9.35
May 510.26 468.16 532.71 12.12
Jun 502.96 479.17 536.16 10.63
Jul 473.08 441.34 498.58 11.48
Aug 474.13 450.66 484.56 7.00
Sep 472.04 451.27 504.23 10.50
Oct 431.02 405.89 460.41 11.84
Nov 408.74 373.67 436.16 14.33
Dec 444.70 412.91 454.98 9.25

Alnylam Pharmaceuticals information and performance

Alnylam Pharmaceuticals Address

675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US

Market Capitalization: 18 813 815 000 $

Market capitalization of the Alnylam Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALNY shares in the company outstanding by the market price of one share.

EBITDA: -228 120 992 $

EBITDA of Alnylam Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -0.49

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -3.52

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.312
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 9.47

Enterprise Value (EV) /Revenue

EV To EBITDA: -80.45

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 125946000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.